StockData
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ) stock

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.48−0.04 (-8.36%)

Close on Nov 17, 2026Market cap $3.14MP/E –Yield –

Creative Medical Technology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Creative Medical Technology's pe ratio was 6.2× on Apr 29, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20226.2×–

More Creative Medical Technology figures

See a number that looks wrong?